Filing Details
- Accession Number:
- 0001628280-23-006539
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 16:36:01
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 16:36:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551306 | Progyny Inc. | PGNY | Services-Misc Health & Allied Services, Nec (8090) | 272220139 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1576145 | J David Schlanger | C/O Progyny, Inc. 1359 Broadway, 2Nd Fl New York NY 10018 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-02 | 41,667 | $0.91 | 117,835 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 33,796 | $35.97 | 84,039 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 7,544 | $36.68 | 76,495 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 327 | $37.78 | 76,168 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-03 | 41,666 | $0.91 | 117,834 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-03 | 41,666 | $36.26 | 76,168 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-03-02 | 41,667 | $0.00 | 41,667 | $0.91 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-03-03 | 41,666 | $0.00 | 41,666 | $0.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 773,894 | 2027-08-03 | No | 4 | M | Direct | |
| 732,228 | 2027-08-03 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.49 to $36.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.51 to $37.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.79 to $36.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These options are fully vested and exercisable.
Billionaire Hedge Funds
